Detailed product information, standard pack sizes and direct quote request for analytical and research use.
| Product Name | Bortezomib |
|---|---|
| CAT No. | HX-O-00482 |
| CAS No. | 179324-69-7 |
| Category | Api Standards |
| Parent API | Bortezomib |
| Molecular Formula | C19H25BN4O4 |
| Molecular Weight | 384.24 |
| Stock Status | In Stock |
| Application | "Bortezomib is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells." |
Bortezomib is listed under Api Standards and may be used for analytical research, method development, method validation, impurity profiling and routine quality control workflows. Documentation such as COA and MSDS can be requested during enquiry.